The FDA has approved Basaglar, a long-acting human insulin analog, to improve glycemic control in adults and children with type 1 diabetes and in adults with type 2 diabetes.
Diabetes
Latest News
Advertisement
CME Content
Advertisement
Recently, researchers identified 5 predictive factors for weight loss extent in overweight patients with type 2 diabetes.
Early diagnosis and management of ketoacidosis is vital.
Pharmacy medication synchronization programs may simplify care for diabetes and other chronic conditions.
Targeting early marker of insulin resistance shows promise in type 2 diabetes.
New therapies on the horizon for cancer, multiple sclerosis, and rheumatoid arthritis.
Top news of the day from across the health care landscape.
When fat tissue becomes altered, the likelihood of inflammation and metabolic disorders increases.
A small proportion of patients with autoimmune syndrome have diabetes.
Statin therapy not found to cause diabetes among patients with low levels of LDL cholesterol.
Pokémon Go may help reduce burdens of obesity and diabetes.
Women with gestational diabetes found to breastfeed less often and for shorter duration.
Top news of the day from across the health care landscape.
Top news of the day from across the healthcare landscape.
The drug prevents against bone loss and fractures associated with type 2 diabetes and osteoporosis.
Heart failure with preserved ejection typically accompanied by hypertension, diabetes, lung disease, or chronic renal failure.
Researchers gain insight on genetic variants that influence the development of type 2 diabetes.
HIV-infected patients are 4 times more likely to develop type 2 diabetes than uninfected individuals.
More than a half-billion people may have diabetes worldwide.
United States Preventive Service Task Force screening guidelines for diabetes found to miss more than half of high-risk patients.
New targeted drug delivery system has the ability to cross the intestinal and blood-brain barriers.
Over the years, a number of landmark clinical studies have been published in the diabetes space and shaped how we treat the disease today.
A free online program called Fit2Me allows T2D patients to tailor 4 key areas of diabetes care to their specific needs
Adlyxin maintains normal A1c levels in patients with type 2 diabetes.
Adlyxin is a once-daily injection that improves glycemic control in type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
Evaluating Pharmacists’ Role In Veterinary Medication Management and Education
4
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
5